V58I (p.Val58Ile) variant of SGCA (Alpha-sarcoglycan)

V58I (p.Val58Ile) in SGCA (Alpha-sarcoglycan) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.20 / 1. The record also includes population frequency data and structural context.

V58I (p.Val58Ile) variant details